María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Shanghai Jiao Tong University
Shangai, ChinaPublikationen in Zusammenarbeit mit Forschern von Shanghai Jiao Tong University (1)
2016
-
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
Annals of Oncology, Vol. 27, Núm. 3, pp. 417-423